Keyphrases
Arginine
100%
Extended Treatment
100%
Thalassemia
100%
Hemoglobinopathies
100%
Butyrate
100%
Sickle Cell Disease
83%
Fetal Hemoglobin
83%
Hemoglobin
33%
Reticulocytes
33%
Hematological Response
33%
Messenger RNA (mRNA)
16%
Intravenous Infusion
16%
Hemoglobin Concentration
16%
Initial Dose
16%
Drug Toxicity
16%
Globin
16%
Grand Mal Seizure
16%
Enhanced Production
16%
Medicine and Dentistry
Arginine
100%
Butyric Acid
100%
Thalassemia
100%
Hemoglobinopathy
100%
Embryonic Hemoglobin
83%
Sickle-Cell Disease
50%
Reticulocyte
33%
Patient with Sickle Cell Disease
33%
Disease
16%
Body Weight
16%
Intravenous Drug Administration
16%
Hemoglobin Determination
16%
Drug Toxicity
16%
Tonic-Clonic Seizure
16%
Globin Messenger RNA
16%
Pharmacology, Toxicology and Pharmaceutical Science
Arginine
100%
Butyrate
100%
Thalassemia
100%
Hemoglobinopathy
100%
Sickle Cell Anemia
83%
Hemoglobin F
83%
Disease
16%
Drug Toxicity
16%
Tonic Clonic Seizure
16%
Globin Messenger RNA
16%